Navigation Links
Psylin Neurosciences Commences Development of Compound for Depression
Date:4/20/2009

in vivo approach to drug discovery," said Emer Leahy, Ph.D., Co-CEO of Psylin and President and CEO of PsychoGenics. "PSN0041 is a very exciting molecule that offers a new approach to the treatment of depression and based on our preclinical models is expected to provide certain unique advantages over existing treatments."

Psylin's mission is to pioneer the development of peptide therapeutics for the treatment of psychiatric disorders. PSN0041 will be the first compound in Psylin's pipeline to enter into clinical development. Other compounds are being investigated for development as antipsychotic and mood stabilizing therapies.

Amylin's proprietary peptide library known as PHORMOL encompasses an extensive panel of potentially valuable biologics that have been taken from nature, including human peptides not previously described. All of these have been synthesized to create a rich source of compounds that are being evaluated for potential utility in a range of diseases.

PsychoGenics' proprietary drug discovery technologies combine its broad in vivo behavioral expertise with recent developments in robotics, computer vision and bio/cheminformatics to evaluate drug candidates for potential utility across the spectrum of neuropsychiatric disease indications. Working in partnership with pharmaceutical and biotech companies, PsychoGenics has been instrumental in identifying therapeutic potential for a variety of early and late stage compounds including some with novel "first-in-class" mechanisms of action such as PSN0041.

About Depression

Depression is the leading major cause of disability in the United States. According to the National Institute of Mental Health, depression affects approximately 19 million people in the United States. The U.S. Surgeon General estimates that the indirect costs attributable to depression amount to $80 billion annually.


'/>"/>

SOURCE Psylin Neurosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Intellect Neurosciences, Inc. Issues Letter to Shareholders From Its Chairman and CEO
2. Blanchette Rockefeller Neurosciences Institute Hosts First-Ever International Forum on Memory and Memory Disorders and Dedicates New $30 Million Research Facility
3. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
4. Intellect Neurosciences, Inc. Receives Notice of Allowance and Completes Grant Requirements for Pivotal European Patent Related to Passive Immunization of Alzheimers Disease
5. Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication
6. Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
7. Amarin Signs Agreement to Acquire Ester Neurosciences
8. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
9. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. BioVex Commences OncoVEX (GM-CSF) Phase 3 Trial in Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... ... Patients , Study will provide new insights on mechanics of fecal microbiota transplantation ... new partnership to study the microbiome of patients undergoing fecal microbiota transplantation (FMT) ...
(Date:6/30/2015)... ... June 30, 2015 , ... The maximum number of shares proposed ... common shares (including shares of unvested restricted stock). On June 29, 2015, the last ... of Cryo-Cell’s shares reported on the OTCBB was $2.29 per share. , The tender ...
(Date:6/30/2015)... , June 30, 2015  Custom Computer Specialists, ... today that they are silver sponsors of the Primary ... PCDC sponsor, Custom is lending their support of PCDC,s ... communities. Since its founding in 1993, PCDC ... primary care area.  PCDC has financed over 100 completed ...
(Date:6/30/2015)... ... 30, 2015 , ... Southern Illinois University Edwardsville Chancellor Julie ... president of instruction at Chippewa Valley Technical College (CVTC) and will assume her ... lead SIUE during the past three years,” Furst-Bowe said. “I want to thank ...
Breaking Biology Technology:uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3Custom Computer Specialists Announces Sponsorship Of The Primary Care Development Corporation's Corporate Circle 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 3
... driving second new office opening in North Carolina in last 12 ... ... N.C., Jan. 17 Quintiles,Transnational Corp. today announced that the global leader ... an expansion of Quintiles, clinical research in pharmaceutical,and biotechnology development., The ...
... Board to advise on cancer screening methods and ... mitochondrial DNA-based disease detection, ... TBIO) today announced that it has formed a Scientific,Advisory ... and,scientific opportunities in cancer detection screening and mitochondrial,disease diagnosis. ...
... Advancement Towards Creating Patient-Specific and Disease-Specific ... Stem Cells For Therapeutic Use, LA ... research company, announced today it has become the,first in the world ... nuclear transfer (SCNT)., Stemagen CEO Samuel H. Wood, M.D., Ph.D., ...
Cached Biology Technology:Quintiles to Open Clinical Research Office in Wilmington, NC 2Transgenomic, Inc. Forms Scientific Advisory Board 2Transgenomic, Inc. Forms Scientific Advisory Board 3Stemagen First to Create Cloned Human Embryos From Adult Cells 2Stemagen First to Create Cloned Human Embryos From Adult Cells 3
(Date:6/16/2015)... , June 16, 2015 Fingerprint ... previously communicated that it will amount to at least 340 ... Due to the rapid increase in market growth and orders ... previously communicated guidance that revenue for 2015 will exceed 1,500 ... amount to approximately 2,200 MSEK. Due to receipt ...
(Date:6/12/2015)... , June 12, 2015  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... patent to electronically capture, analyze and identify participants ... recognition methods. This system can: ... an enrollment and subsequent sign-on process is actually ...
(Date:6/9/2015)... 2015 Research and Markets  ( http://www.researchandmarkets.com/research/xsgs2s/gesture ... "Gesture Recognition & Touchless Sensing Market by Technology ... Others), Product (Biometric & Sanitary Equipment) & by ... to their offering. The total gesture ... reach $ 23.55 Billion by 2020 at a ...
Breaking Biology News(10 mins):Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2Global Gesture Recognition & Touchless Sensing (Technology, Application & Products) Market 2015-2020 2
... the University of Bonn, working in collaboration with scientists ... previously unknown regulatory mechanism in the process of bone ... the treatment of osteoporosis. More than four million people, ... illness in Germany alone. In recognition of the importance ...
... L-arginine following a heart attack does not improve certain ... an increased risk of death, according to a study ... is a widely available dietary supplement and is publicized ... failure and sexual dysfunction, according to background information in ...
... The discovery of a possible hibernation hormone in the ... researchers reported in the April 7, 2006 issue of ... survive unscathed--in a state of suspended animation--under the harshest ... are confirmed, the hormone would represent the first essential ...
Cached Biology News:New weapon in battle against osteoporosis 2New weapon in battle against osteoporosis 3An elephant tail 2Possible brain hormone may unlock mystery of hibernation 2Possible brain hormone may unlock mystery of hibernation 3
RABBIT ANTI RAT AQUAPORIN 5...
... 0.2 and 2.0 mL samples for freezing point determinations. Includes built-in printer, ... capability with optional scanner. RS-232 port. Microprocessor-controlled autocalibration. Two-step Calibration. ... ... ...
MAb to Hu-IFN-Gamma RC2 (CD118), NON-Neutralizing, Clone MMHGR-2 Binds to but does not neutralize human interferon gamma receptor...
Recombinant Rat CINC-2 alpha, CF...
Biology Products: